1 Lakh
Investment Grown to₹ 10000
Monthly SIP Grown toSuitability:
This is a fund that invests mainly in shares of pharmaceutical and healthcare companies.
We believe that investors should avoid funds that have a narrowly defined investment mandate such as this one. Instead, they should invest in multi-cap funds which provide complete freedom to the fund management team to invest in companies from which it expects maximum gains.
But if you do invest, you must do so only through the SIP route. Click here to read a primer on SIP investing.
Warning: Do not invest in this, or any other pharma sector fund, if you need to redeem your investment in less than seven years.
Taxability of earnings:
Capital gains
Dividends
Please wait...
Please wait...
| YTD | 1-Day | 1-W | 1-M | 3-M | 6-M | 1-Y | 3-Y | 5-Y | 7-Y | 10-Y | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Fund | 7.88 | -0.89 | -0.27 | 3.84 | 5.42 | 17.44 | 63.78 | -- | -- | -- | -- |
| S&P BSE Healthcare TRI | 11.33 | -1.20 | 0.18 | 7.58 | 10.70 | 21.09 | 60.35 | -- | -- | -- | -- |
| Equity: Sectoral-Pharma | 10.36 | -1.03 | 0.48 | 7.57 | 9.96 | 21.28 | 58.09 | -- | -- | -- | -- |
| Rank within category | 9 | 2 | 9 | 9 | 9 | 9 | 2 | -- | -- | -- | -- |
| Number of funds in category | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 4 | 4 | 3 | 0 |
As on 14-May-2021
| Fund name | Rating | Launch Date | 1-Year Return | 3-Year Return | 5-Year Return | Expense Ratio | Assets (Cr) |
|---|---|---|---|---|---|---|---|
| DSP Healthcare Fund - Direct Plan | Invest Online | Nov-18 | 63.78 | -- | -- | 0.75 | 1,236 | |
| Nippon India Pharma Fund - Direct Plan | Jan-13 | 61.07 | 28.47 | 17.52 | 0.80 | 4,812 | |
| ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund - Direct Plan | Invest Now | Jul-18 | 64.53 | -- | -- | 1.42 | 2,549 | |
| SBI Healthcare Opportunities Fund - Direct Plan | Invest Online | Jan-13 | 61.63 | 24.55 | 11.06 | 1.11 | 1,748 | |
| Mirae Asset Healthcare Fund - Direct Plan | Invest Online | Jul-18 | 60.44 | -- | -- | 0.50 | 1,459 |
| Best Performance | Worst Performance | |||
|---|---|---|---|---|
| Return (%) | Period | Return (%) | Period | |
| Week | 15.08 | 01-Apr-2020 - 09-Apr-2020 | -12.80 | 11-Mar-2020 - 18-Mar-2020 |
| Month | 28.70 | 23-Mar-2020 - 22-Apr-2020 | -21.74 | 20-Feb-2020 - 23-Mar-2020 |
| Quarter | 42.77 | 23-Mar-2020 - 22-Jun-2020 | -8.78 | 23-Dec-2019 - 23-Mar-2020 |
| Year | 97.11 | 23-Mar-2020 - 23-Mar-2021 | -3.97 | 22-Mar-2019 - 23-Mar-2020 |
| Mean | Std Dev | Sharpe | Sortino | Beta | Alpha | |
|---|---|---|---|---|---|---|
| Fund | -- | -- | -- | -- | -- | -- |
| S&P BSE Healthcare TRI* | 20.37 | 23.71 | 0.67 | 1.50 | -- | -- |
| Equity: Sectoral-Pharma* | 22.84 | 21.25 | 0.87 | 1.81 | 0.87 | 4.51 |
| Rank within category | -- | -- | -- | -- | -- | -- |
| Number of funds in category | -- | -- | -- | -- | -- | -- |
The Risk Measures have been calculated using calendar month returns for the last three years.
As on
* As on 30-Apr-2021
Please wait...
| Number of Stocks | 24 |
| Top 10 Stocks (%) | 61.71 |
| Top 5 Stocks (%) | 38.40 |
| Top 3 Sectors (%) | 93.54 |
| Portfolio P/B Ratio | 4.97 |
| Portfolio P/E Ratio | 43.88 |
| Fund | Category | |
|---|---|---|
| Average Mkt Cap (Rs Cr) | 42,066 | 43,624 |
| Giant (%) | 13.82 | 11.37 |
| Large (%) | 45.50 | 53.52 |
| Mid (%) | 31.36 | 26.50 |
| Small (%) | 9.33 | 8.61 |
| Tiny (%) | -- | 0.03 |
Please wait...
| Company | Sector | P/E | 3Y High | 3Y Low | % Assets | |
|---|---|---|---|---|---|---|
|
Sun Pharmaceutical Inds. | Healthcare | 68.82 | 14.33 | 0.00 | 8.77 |
|
Cipla | Healthcare | 30.32 | 9.58 | 0.00 | 8.69 |
|
|
Lupin | Healthcare | 43.97 | 8.03 | 0.00 | 7.23 |
|
|
Dr. Reddy's Lab | Healthcare | 44.28 | 10.41 | 5.33 | 6.99 |
|
|
Ipca Laboratories | Healthcare | 25.60 | 11.48 | 6.13 | 6.72 |
|
|
Divi's Laboratories | Healthcare | 57.08 | 8.41 | 3.98 | 5.52 |
|
|
Apollo Hospitals | Healthcare | 223.63 | 5.97 | 1.69 | 5.44 |
|
|
Max Healthcare Institute | Healthcare | 222.54 | 4.95 | 0.00 | 4.90 |
|
|
Procter & Gamble Health | Healthcare | 49.95 | 6.12 | 0.00 | 4.39 |
|
|
Intuitive Surgical Inc. (USA) | Healthcare | -- | 3.23 | ||
|
|
Dr. Lal Pathlabs | Healthcare | 94.23 | 3.33 | 1.27 | 3.06 |
|
|
Torrent Pharmaceuticals | Healthcare | 37.09 | 4.77 | 2.46 | 2.88 |
|
|
ICICI Lombard General Insurance Company | Financial | 45.48 | 3.77 | 1.17 | 2.76 |
|
|
Abiomed Inc | Healthcare | -- | 2.59 | ||
|
|
Indoco Remedies | Healthcare | 44.38 | 5.43 | 2.22 | 2.47 |
|
JB Chemicals & Pharma | Healthcare | 26.94 | 9.22 | 2.36 | 2.36 |
|
|
Abbott Laboratories | Healthcare | -- | 2.29 | ||
|
|
Narayana Hrudayalaya | Healthcare | -- | 3.12 | 0.00 | 2.17 |
|
|
Syngene International | Healthcare | 56.12 | 3.77 | 1.97 | 2.08 |
|
|
Alkem Laboratories | Healthcare | 23.35 | 5.53 | 1.54 | 1.94 |
|
Globus Medical Inc | Healthcare | -- | 1.82 | ||
|
|
Alembic Pharmaceuticals | Healthcare | 16.09 | 3.90 | 1.78 | 1.78 |
|
|
Aarti Drugs | Healthcare | 26.50 | 5.29 | 1.75 | 1.75 |
|
|
Unichem Laboratories | Healthcare | 134.51 | 4.31 | 1.65 | 1.71 |
Indicates an increase or decrease or no change in holding since last portfolio
Indicates a new holding since last portfolio
As on 30-Apr-2021
— Chirag Dagli since 01-Dec-2020
Education: Mr. Dagli has done B. COM and Chartered Accountant.
Experience: Prior to joining DSP Mutual Fund, he has worked with HDFC AMC, Aviva India Life Insurance Company Ltd., ICICI Securities Ltd., Pioneer Invest Corp, Deutsche Equities, Citigroup Global Markets.
— Vinit Sambre since 12-Nov-2018
Education: Mr. Sambre is a B.Com and FCA.
Experience: Prior to joining DSP he was associated with DSP Merrill Lynch Ltd.(Nov 2005 to Jun 2007), IL & FS Investsmart Ltd. (Dec 2002 to Oct 2005), Unit Trust of India Investment Advisory Services Ltd.(Jun 2000 to Dec 2002), Kisan Ratilal Choksey Shares and Securities Pvt. Ltd. (March 1999 to May 2000) and Credit Rating Information Service of India Ltd.(Apr 1998 to Feb 1999).
Interviews:
Funds Managed:
Personal finance advice and mutual fund ideas delivered to your inbox every Monday
The scheme seeks to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies.
| Minimum Investment (₹) | 500 |
| Minimum Addl Investment (₹) | 500 |
| Minimum SIP Investment (₹) | 500 |
| Minimum No of Cheques | 12 |
| Minimum Withdrawal (₹) | 500 |
| Minimum Balance (₹) | 500 |
| Lock-in Period | Not Applicable |
| Exit Load | 1% for redemption within 364 days |
| Fund House: | DSP Mutual Fund |
| Launch Date: | 30-Nov-2018 |
| Return Since Launch: | 36.75% |
| Benchmark: | S&P BSE Healthcare TRI |
| Riskometer: | Very High |
| Type: | Open-ended |
| Assets: | ₹ 1,236 Cr (As on 30-Apr-2021) |
| Expense: | 0.75% (As on 30-Apr-2021) |
| Risk Grade: | -- |
| Return Grade: | -- |
| Turnover: | 16.00% |
| Plan | Record Date | Dividend (₹ / Unit) | |
|---|---|---|---|
| IDCW | 25-Mar-2021 | 1.9200 |
Fund News - 23-Nov-2020
AMC: DSP Investment Managers Pvt. Ltd.
Address: NATRAJ, Office No. 302-3rd Floor-Plot No. 194, MV Road Junction Western Express Highway, Andheri East Mumbai - 400069
Phone: 022-66178000
Fax: 022-56578181
Website: https://www.dspim.com/
Registrar & Transfer Agent: Computer Age Management Services Ltd.
Address: 7th Floor, Tower II, Rayala Towers, 158, Anna Salai, Chennai - 600002
Phone: 1800-3010-6767 / 1800-419-7676
Fax: 044-30407101
Email: [email protected]
Website: www.camsonline.com
Friday, 07-May-2021
12:30 PM - 01:00 PM
Registration Over
